Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice

  • Authors:
    • Ping Li
    • Jie Cao
    • Yifei Chen
    • Wei Wang
    • Jiong Yang
  • View Affiliations

  • Published online on: May 6, 2014     https://doi.org/10.3892/ijmm.2014.1771
  • Pages: 269-275
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent studies have demonstrated that extracellular adenosine 5'-triphosphate (eATP) is involved in allergic airway inflammation by activating purinergic receptors. eATP can be hydrolyzed by ectonucleotidases, such as CD39. In this study, we investigated the expression and distribution of CD39 in the lungs of mice, as well as the effects of apyrase on airway inflammation and the chemotactic migration of dendritic cells (DCs). A mouse model of asthma was developed with chicken ovalbumin (OVA)/aluminum hydroxide using female C57BL/6 mice. Apyrase was administered to OVA-sensitized mice prior to each challenge by intraperitoneal injection. The distribution of CD39 was detected by immunofluorescence. The mRNA and protein expression of CD39 was determined by quantitative PCR and western blot analysis, respectively. The levels of Th2 cytokines in the bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent assay (ELISA). The effect of apyrase on the chemotactic migration of DCs towards ATP was explored by migration assay in vitro. In the lungs, CD39 was primarily located in the cytoplasm and cytomembrane of bronchial epithelial cells and CD39 expression was reduced in mice with allergic asthma. Treatment with apyrase markedly attenuated OVA-induced airway inflammation, including peribronchial eosinophilic inflammation and reduced the number of inflammatory cells, as well as the levels of cytokines in BALF. Furthermore, apyrase also markedly reduced the expression of GATA binding protein 3 (GATA3) and decreased the chemotactic migration of DCs towards ATP.Our data demonstrate that a reduction in CD39 expression may be associated with the development of allergic airway inflammation and that apyrase alleviates airway inflammation by decreasing the chemotactic migration of DCs towards eATP. Therefore, targeting at eATP or ectonucleotidases may provide a novel therapeutic approach for allergic asthma.

References

1 

Lloyd CM and Hessel EM: Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immun. 10:838–848. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Adcock IM, Caramori G and Chung KF: New targets for drug development in asthma. Lancet. 372:1073–1087. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Holgate ST and Polosa R: Treatment strategies for allergy and asthma. Nat Rev Immunol. 8:218–230. 2008. View Article : Google Scholar

4 

Lambrecht BN and Hammad H: Biology of lung dendritic cells at the origin of asthma. Immunity. 31:412–424. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Kim HY, DeKruyff RH and Umetsu DT: The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol. 11:577–584. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Trautmann A: Extracellular ATP in the immune system: more than just a ‘danger signal’. Sci signal. 2:pe62009.

7 

Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K and Enjyoji K: Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost. 31:217–233. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Idzko M, Hammad H, van Nimwegen M, et al: Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med. 13:913–919. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Müller T, Robaye B, Vieira RP, et al: The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy. 65:1545–1553. 2010.PubMed/NCBI

10 

Müller T, Vieira RP, Grimm M, et al: A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol. 44:456–464. 2011.PubMed/NCBI

11 

Manthei DM, Jackson DJ, Evans MD, et al: Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol. 130:496–502. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Crikis S, Lu B, Murray-Segal LM, et al: Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant. 10:2586–2595. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Künzli BM, Berberat PO, Dwyer K, et al: Variable impact of CD39 in experimental murine colitis. Dig Dis Sci. 56:1393–1403. 2011.PubMed/NCBI

14 

Künzli BM, Nuhn P, Enjyoji K, et al: Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology. 134:292–305. 2008.PubMed/NCBI

15 

Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB and Robson SC: CD39 and control of cellular immune responses. Purinergic Signal. 3:171–180. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Deaglio S and Robson SC: Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol. 61:301–332. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Antonioli L, Pacher P, Vizi ES and Haskó G: CD39 and CD73 in immunity and inflammation. Trends Mol Med. 19:355–367. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Kwak YG, Song CH, Yi HK, et al: Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 111:1083–1092. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Idzko M, Dichmann S, Ferrari D, et al: Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood. 100:925–932. 2002. View Article : Google Scholar

20 

Enjyoji K, Sévigny J, Lin Y, et al: Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 5:1010–1017. 1999. View Article : Google Scholar : PubMed/NCBI

21 

Kapojos JJ, van den Berg A, Borghuis T, et al: Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro. Eur J Pharmacol. 501:191–198. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Heine P, Braun N, Sévigny J, Robson SC, Servos J and Zimmermann H: The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. Eur J Biochem. 268:364–373. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Paletta-Silva R and Meyer-Fernandes JR: Adenosine and immune imbalance in visceral leishmaniasis: the possible role of ectonucleotidases. J Trop Med. 2012:6508742012. View Article : Google Scholar : PubMed/NCBI

24 

Souza Vdo C, Schlemmer KB, Noal CB, et al: E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas’ disease. Parasitol Int. 61:690–696. 2012.PubMed/NCBI

25 

Fan J, Zhang Y, Chuang-Smith ON, et al: Ecto-5′-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. PloS One. 7:e380592012.

26 

Théâtre E, Frederix K, Guilmain W, et al: Overexpression of CD39 in mouse airways promotes bacteria-induced inflammation. J Immunol. 189:1966–1974. 2012.PubMed/NCBI

27 

Fletcher JM, Lonergan R, Costelloe L, et al: CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol. 183:7602–7610. 2009.PubMed/NCBI

28 

Moncrieffe H, Nistala K, Kamhieh Y, et al: High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol. 185:134–143. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Peelen E, Damoiseaux J, Smolders J, et al: Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Neuroimmunol. 240–241:97–103. 2011.PubMed/NCBI

30 

Hart ML, Gorzolla IC, Schittenhelm J, Robson SC and Eltzschig HK: SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol. 184:4017–4024. 2010. View Article : Google Scholar

31 

Bönner F, Borg N, Burghoff S and Schrader J: Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PloS One. 7:e347302012.PubMed/NCBI

32 

Friedman DJ, Künzli BM, A-Rahim YI, et al: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Nat Acad Sci USA. 106:16788–16793. 2009. View Article : Google Scholar

33 

Chen X, Gao YD and Yang J: Elevated interferon regulatory factor 4 levels in patients with allergic asthma. J Asthma. 49:441–449. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Stellato C, Gubin MM, Magee JD, et al: Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J Immunol. 187:441–449. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July 2014
Volume 34 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, P., Cao, J., Chen, Y., Wang, W., & Yang, J. (2014). Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice. International Journal of Molecular Medicine, 34, 269-275. https://doi.org/10.3892/ijmm.2014.1771
MLA
Li, P., Cao, J., Chen, Y., Wang, W., Yang, J."Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice". International Journal of Molecular Medicine 34.1 (2014): 269-275.
Chicago
Li, P., Cao, J., Chen, Y., Wang, W., Yang, J."Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice". International Journal of Molecular Medicine 34, no. 1 (2014): 269-275. https://doi.org/10.3892/ijmm.2014.1771